V
Vivoo
Custom nutrition advice to the users based on their urine sample analysis
About Vivoo
Vivoo operates in the personalized wellness market, offering at-home urine tests that provide users with tailored health insights and expert advice. The company's core product is a mobile app that analyzes urine samples using machine learning technology to deliver personalized recommendations on nutrition, hydration, and overall wellness. Vivoo primarily serves health-conscious individuals looking to take proactive steps in managing their well-being. The business model revolves around selling test kits and offering subscription-based services for continuous health monitoring. Revenue is generated through the sale of these kits and recurring subscription fees. The company aims to make health monitoring accessible and integral to everyday life, leveraging advanced technology to provide actionable insights.
Source: Dealroom company dataAt a glance
- Founded
- 2017
- Headquarters
- San Francisco, United States
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
500 Global
Techstars
Mindshift Capital
Series A7 investors entered at this stage
Draper Associates
Global Ventures
Halogen Ventures
Revo Capital- OVONCE Ventures
Istanbul Technical University
Caucasus Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vivoo on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vivoo on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.